Nutraceuticals and functional foods

Handbook of Nutraceuticals and Functional Foods, Second Edition

Volumn , Issue , 2016, Pages 1-21

  Wildman, Robert E C ^a   Kelley, Mike ^a  

^a Research and Technology Development   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85014963436     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (31)

1. http://www.obesity.chair.ulaval.ca/index.htm.
2. Kalra, E.K. Nutraceutical - Definition and Introduction. AAPS PharmSci 2003; 5: Article 25 (found at http://www.aapsj.org/).
3. DeFelice, S.L. What is a true nutraceutical? And what is the nature and size of the U.S. Market? 1994 http://www.fimdefelice.org/archives/arc.whatisnut.html.
4. International Food Information Council Web site, http://ific.org/nutrition/functional/index.cfm, 2006.
5. International Life Sciences Institute of North America Web site, http://www.ilsi.org/, 2006.
6. Health Canada Web site, http://www.hc-sc.gc.ca, 2006.
7. American Dietetics Association. Position of the American Dietetic Association: functional foods position statement. J. Am. Diet. Assoc., 104: 814-826, 2004.
8. Nutrition Business Journal. Weight Loss and Sport Nutrition Review 2005.
9. U.S. Food and Drug Administration, Center for Food Safety and Applied Nutrition, A Food Labeling Guide, September 1994, http://www.cfsan.fda.gov.
10. Miller, E.G., Gonzales-Sanders, A.P., Couvillon, A.M., Binnie, W.H., Hasegawa, S., and Lam, L.K.T., Citrus liminoids as inhibitors of oral carcinogenesis, Food Technol., 110-114, 1994.
11. Fong, C.H., Hasegawa, S., Herman, Z., and Ou, P., Liminoid glucosides in commercial citrus juices, J. Food Sci., 54: 1505-1506, 1990.
12. Yu, R., Yamada, A., Watanabe, K., Yazawa, K., Takeyama, H., Matsunaga, T., and Kurane, R., Lipids, 35(10): 1061-4, 2000.
13. Wierenga, D.E. and Eaton, C.R., Phases of Drug Development, found at http://www.allp.com/drug_ dev.htm.
14. Novartis Institutes for Biomedical Research, The Drug Development Process at Novartis, found at http://www.nibr.novartis.com/OurScience/drug_development.shtml.
15. Shaw, D., Leon, C., Kolev, S., and Murray V., Traditional remedies and food supplements: a 5-year toxicological study (1991-1995), Drug Saf. 17: 342-56, 1997.
16. Taiz, L. and Zeiger, E., Plant defenses, in Plant Physiology, 2nd ed., Sinauer Associates, Sunderland, MA, 1998.
17. Wattenberg, L.W. and Lam, L.K.T., Protective effects of coffee constituents on carcinogenesis in experimental animals, Banbury Rep., 17: 137-145, 1984.
18. Miller, E.G., McWhorter, K., Rivera-Hidalgo, F., Wright, J.M., Hirsbrunner, P., and Sunahara, G.I., Kahweol and cafestol: inhibitors of hampster buccal pouch carcinogenesis, Nutr. Cancer, 15: 41-46, 1991.
19. Miller, E.G., Gonzalez-Sanders, A.P., Couvillon, A.M., Binnie, W.H., Hasegawa, S, and Lam, L.K.T., Citrus limonoids as inhibitors of oral carcinogenesis, Food Technol., 110-114, 1994.
20. Hasegawa, S., Bennet, R.D., Herman, Z., Fong, C.H., and Ou, P., Limonoids glucosides in citrus, Phytochemistry, 28: 1717-1720, 1989.
21. Chang, M.S., Lee, S.G., and Rho, H.M., Transcriptional activation of Cu/Zn superoxide dismutase and catalase genes by panaxadiol ginsenosides extracted from Panax ginseng, Phytother. Res., 13(8):641-644, 1999.
22. Lee, S.J., Sung, J.H., Lee, S.J., Moon, C.K., and Lee, B.H., Antitumor activity of a novel ginseng saponin metabolite in human pulmonary adenocarcinoma cells resistant to cisplatin, Cancer Lett., 144(1): 39-43, 1999.
23. Craig, W.J., Health-promoting properties of common herbs, Am. J. Clin. Nutr., 70(3 Suppl.):491S-499S, 1999.
24. Wattenberg, L.W., Inhibition of neoplasia by minor dietary constituents, Cancer Res., 43:2448s-2453s, 1994.
25. Wildman, R.E.C. and Medeiros, D.M., Food in relation to the human body, in Advanced Human Nutrition, CRC Press, Boca Raton, FL, 2000.
26. Wildman, R.E.C. and Medeiros, D.M., Carbohydrates, in Advanced Human Nutrition, CRC Press, Boca Raton, FL, 1999.
27. Babayan, V.K., Medium chain triglycerides and structured lipids, Lipids, 22(6): 417-20, 1987.
28. Tso, P., Lee, T., Demichele, S.J., Lymphatic absorption of structured triglycerides vs. physical mix in a rat model of fat malabsorption, Am. J. Physiol., 277(2 Pt. 1): G333-40, 1999.
29. Rudkowska, I., Roynette, C.E., Demonty, I., Vanstone, C.A., Jew, S., Jones, P.J., Diacylglycerol:efficacy and mechanism of action of an anti-obesity agent. Obes Res. 13(11): 1864-76, 2005.
30. Nittynen, L., Nurminen, M.L., Korpela, R., and Vapaatalo, H., Role of arginine, taurine and homocysteine in cardiovascular diseases, Ann. Med., 31(5): 318-326, 1999.
31. Wildman, R.E.C. and Medeiros, D.M., Nutrition and cardiovascular disease, in Advanced Human Nutrition, CRC Press, Boca Raton, FL, 2000.